Abacavir Sulfate; Lamivudine Patent Expiration

Abacavir Sulfate; Lamivudine is Used for treating HIV infection. It was first introduced by Viiv Healthcare Co in its drug Epzicom on Aug 2, 2004. Another drug containing Abacavir Sulfate; Lamivudine is Abacavir Sulfate And Lamivudine. 11 different companies have introduced drugs containing Abacavir Sulfate; Lamivudine.


Abacavir Sulfate; Lamivudine Patents

Given below is the list of patents protecting Abacavir Sulfate; Lamivudine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Epzicom US6294540

(Pediatric)

Carbocyclic nucleoside hemisulfate and its use in treating viral infections Nov 14, 2018

(Expired)

Viiv Hlthcare
Epzicom US6294540 Carbocyclic nucleoside hemisulfate and its use in treating viral infections May 14, 2018

(Expired)

Viiv Hlthcare
Epzicom US5905082

(Pediatric)

Crystalline oxathiolane derivatives Nov 18, 2016

(Expired)

Viiv Hlthcare
Epzicom US6417191

(Pediatric)

Synergistic combinations of zidovudine, 1592U89 and 3TC Sep 28, 2016

(Expired)

Viiv Hlthcare
Epzicom US5905082 Crystalline oxathiolane derivatives May 18, 2016

(Expired)

Viiv Hlthcare
Epzicom US6417191 Synergistic combinations of zidovudine, 1592U89 and 3TC Mar 28, 2016

(Expired)

Viiv Hlthcare



Abacavir Sulfate; Lamivudine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abacavir Sulfate; Lamivudine Generic API Manufacturers

Several generic applications have been filed for Abacavir Sulfate; Lamivudine. The first generic version for Abacavir Sulfate; Lamivudine was by Teva Pharmaceuticals Usa and was approved on Sep 29, 2016. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Apr 16, 2025.

Given below is the list of companies who have filed for Abacavir Sulfate; Lamivudine generic, along with the locations of their manufacturing plants worldwide.